Maya Martinez-Davis
Corporate Officer/Principal at GSK PLC
Maya Martinez-Davis active positions
Companies | Position | Start | End |
---|---|---|---|
GSK PLC | Corporate Officer/Principal | 01/01/2020 | - |
Career history of Maya Martinez-Davis
Former positions of Maya Martinez-Davis
Companies | Position | Start | End |
---|---|---|---|
MIRATI THERAPEUTICS | Director/Board Member | 06/12/2018 | 23/01/2024 |
Independent Dir/Board Member | 06/12/2018 | 23/01/2024 | |
MERCK KGAA | Corporate Officer/Principal | 01/01/2016 | 01/08/2019 |
Training of Maya Martinez-Davis
St. Louis University | Undergraduate Degree |
Instituto de Empresa SL | Graduate Degree |
Statistics
International
Spain | 3 |
Germany | 2 |
United Kingdom | 2 |
Operational
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
MERCK KGAA | Health Technology |
GSK PLC | Health Technology |
Private companies | 1 |
---|---|
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Maya Martinez-Davis
- Experience